Yamazaki M, Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Nakamura S, Naito T, Ohta H
Department of Internal Medicine (III), Kanazawa University of Medicine, Japan.
Blood Coagul Fibrinolysis. 1993 Jun;4(3):491-5. doi: 10.1097/00001721-199306000-00014.
We report a 74-year-old Japanese woman who had bleeding due to a factor VIII inhibitor in the absence of diseases known to be associated with its development. She abruptly developed a large painful purpura extending from the right hip to the thigh followed by an intramuscular haematoma of her left anterior chest. Examinations revealed a marked depression of factor VIII activity (5%) and the presence of 31 Bethesda units/ml factor VIII inhibiting activity. The phenotypes of these inhibitors were of the IgG-kappa and IgG-lambda types. She was treated with oral prednisolone and double filtration plasmapheresis (DFPP). The inhibitors rapidly disappeared after three sessions of plasmapheresis and her plasma factor VIII activity increased to a normal level. During this treatment, no major adverse effects such as thrombosis and infection were observed and transfusion of fresh frozen plasma (FFP) was not necessary. Heterogeneity of idiopathic factor VIII inhibitors in elderly patients is common and spontaneous disappearance or elimination of such inhibitors by treatment is often difficult to achieve. However, the combination of oral prednisolone and double filtration plasmapheresis is effective and safe for idiopathic factor VIII inhibitors and is a worthwhile approach to treatment.
我们报告了一名74岁的日本女性,她在没有已知与其发生相关疾病的情况下,因VIII因子抑制剂而出血。她突然出现从右臀部延伸至大腿的大片疼痛性紫癜,随后左前胸出现肌肉内血肿。检查发现VIII因子活性显著降低(5%),且存在31 Bethesda单位/毫升的VIII因子抑制活性。这些抑制剂的表型为IgG-κ和IgG-λ型。她接受了口服泼尼松龙和双重滤过血浆置换(DFPP)治疗。经过三次血浆置换治疗后,抑制剂迅速消失,她的血浆VIII因子活性恢复到正常水平。在治疗期间,未观察到血栓形成和感染等重大不良反应,也无需输注新鲜冰冻血浆(FFP)。老年患者特发性VIII因子抑制剂的异质性很常见,此类抑制剂自发消失或通过治疗消除往往难以实现。然而,口服泼尼松龙和双重滤过血浆置换联合使用对特发性VIII因子抑制剂有效且安全,是一种值得采用的治疗方法。